iBio (IBIO) Non Operating Income (2010 - 2026)
iBio's (IBIO) quarterly Non Operating Income came in at $635000.0 in Q1 2026, up 3427.78% year-on-year from $18000.0 in Q1 2025, and up 40.49% on a QoQ basis from $452000.0 in Q4 2025.
iBio (IBIO) Non Operating Income (2010 - 2026) Analysis & Trends
iBio (IBIO) has 17 years of Non Operating Income data on file, last reported at $635000.0 in Q1 2026.
- On a quarterly basis, Non Operating Income rose 3427.78% year-over-year to $635000.0 in Q1 2026; TTM through Mar 2026 was $1.4 million, a 283.29% increase from a year earlier, with the FY2025 full-year figure at $225000.0, down 81.11% from the prior year.
- Non Operating Income for Q1 2026 stood at $635000.0, up from $452000.0 in the prior quarter.
- Over the last five years, Non Operating Income for IBIO reached as high as $991000.0 in Q1 2024 and fell as low as -$110000.0 in Q1 2023.
- Historically, Non Operating Income has averaged $169058.8 across 5 years, with a median of $55000.0 in 2024.
- Across the five-year window, Non Operating Income slumped 361.9% in 2023 and jumped 3427.78% in 2026, its largest moves.
- Year by year, Non Operating Income stood at $10000.0 in 2022, then declined by 20.0% to $8000.0 in 2023, then surged by 587.5% to $55000.0 in 2024, then jumped by 721.82% to $452000.0 in 2025, then surged by 40.49% to $635000.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were $635000.0 in Q1 2026, $452000.0 in Q4 2025, and $231000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -8.59 Mn |
| 10 | iBio | 172.22 Mn | 172.22 Mn | - | 635,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 635,000.00 |
| Dec 31, 2025 | 452,000.00 |
| Sep 30, 2025 | 231,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 18,000.00 |
| Dec 31, 2024 | 55,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Jun 30, 2024 | 163,000.00 |
| Mar 31, 2024 | 991,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Sep 30, 2023 | 29,000.00 |
| Jun 30, 2023 | 33,000.00 |
| Mar 31, 2023 | -110,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Sep 30, 2022 | 99,000.00 |
| Jun 30, 2022 | 66,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 40,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Jun 30, 2021 | 9.55 Mn |